Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost in Female Pattern Hair Loss
NCT01325350Phase 2Completed
- Sponsor
- Allergan
- Start
- Jun 2011
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of bimatoprost in Female Pattern Hair Loss (FPHL) (5 arms), sponsored by Allergan. Primary endpoints: Target Area Hair Count at 6 months and Subject Self Assessment at 6 months. Started Jun 2011; status: completed.
02
Drugs
bimatoprost
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on NCT01325350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01325350.